China National Medicines Corporation Ltd. (SHA: 600511)
China
· Delayed Price · Currency is CNY 29.05
0.00 (0.00%)
Sep 6, 2024, 3:00 PM CST
China National Medicines Corporation Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 2,162 | 2,146 | 1,964 | 1,754 | 1,383 | 1,604 | Upgrade
|
| Depreciation & Amortization | 211.74 | 192.82 | 189.61 | 178.83 | 172.6 | 130.27 | Upgrade
|
| Other Amortization | 20.24 | 15.74 | 7.84 | - | 5.13 | 4.94 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.43 | -0.08 | -1.68 | - | -0.07 | 0.53 | Upgrade
|
| Asset Writedown & Restructuring Costs | -0.31 | -0.33 | 5.23 | - | 6.5 | 0.1 | Upgrade
|
| Loss (Gain) From Sale of Investments | -377.92 | -369.77 | -291.62 | - | -220.6 | -114.59 | Upgrade
|
| Provision & Write-off of Bad Debts | 11.29 | 9.17 | 23.8 | - | 9.32 | 15.97 | Upgrade
|
| Other Operating Activities | 196.28 | 228.33 | 203.37 | 24.54 | 164.44 | 309.77 | Upgrade
|
| Change in Accounts Receivable | -626.21 | -292.55 | 599.77 | - | -107.14 | -1,633 | Upgrade
|
| Change in Inventory | -1,015 | -243.6 | -207.59 | - | 300.41 | -12.95 | Upgrade
|
| Change in Accounts Payable | 1,240 | 1,048 | -87.62 | - | -411.41 | 1,511 | Upgrade
|
| Change in Other Net Operating Assets | 4.19 | - | - | - | 0.77 | 0.3 | Upgrade
|
| Operating Cash Flow | 1,827 | 2,727 | 2,395 | 1,957 | 1,302 | 1,776 | Upgrade
|
| Operating Cash Flow Growth | -16.74% | 13.84% | 22.36% | 50.38% | -26.71% | 80.93% | Upgrade
|
| Capital Expenditures | -138.91 | -145.12 | -129.78 | -95.07 | -69.05 | -85.72 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.15 | 0.16 | 3.52 | 0.78 | 1.3 | 0.93 | Upgrade
|
| Cash Acquisitions | - | - | -15.2 | -15.82 | 1.21 | -31.81 | Upgrade
|
| Investment in Securities | 17.44 | 7.88 | -12.6 | -15.75 | 2.87 | -0.9 | Upgrade
|
| Other Investing Activities | -61.03 | 7.77 | 1.74 | 2.86 | 7.21 | 132.16 | Upgrade
|
| Investing Cash Flow | -182.35 | -129.31 | -152.32 | -122.99 | -56.47 | 14.66 | Upgrade
|
| Short-Term Debt Issued | - | 203.2 | 335.61 | 793.18 | 1,184 | 830.58 | Upgrade
|
| Total Debt Issued | 190.59 | 203.2 | 335.61 | 793.18 | 1,184 | 830.58 | Upgrade
|
| Short-Term Debt Repaid | - | -250 | -509.86 | -864.55 | -1,061 | -1,508 | Upgrade
|
| Long-Term Debt Repaid | - | -81.71 | -117.07 | -72.35 | -60.05 | -34.95 | Upgrade
|
| Total Debt Repaid | -554.42 | -331.71 | -626.93 | -936.91 | -1,121 | -1,542 | Upgrade
|
| Net Debt Issued (Repaid) | -363.83 | -128.51 | -291.32 | -143.72 | 62.86 | -711.92 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | - | -0 | Upgrade
|
| Common Dividends Paid | -758.73 | -709.58 | -611.96 | -637.77 | -613.06 | -457.88 | Upgrade
|
| Other Financing Activities | 205.79 | 205.91 | 263.71 | 35.53 | -180.41 | -47.02 | Upgrade
|
| Financing Cash Flow | -916.77 | -632.18 | -639.57 | -745.96 | -730.61 | -1,217 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | -0.02 | -0.68 | Upgrade
|
| Net Cash Flow | 727.62 | 1,965 | 1,603 | 1,088 | 514.57 | 573.23 | Upgrade
|
| Free Cash Flow | 1,688 | 2,582 | 2,265 | 1,862 | 1,233 | 1,690 | Upgrade
|
| Free Cash Flow Growth | -17.28% | 13.96% | 21.64% | 51.09% | -27.08% | 99.05% | Upgrade
|
| Free Cash Flow Margin | 3.35% | 5.19% | 4.98% | 4.01% | 3.05% | 3.79% | Upgrade
|
| Free Cash Flow Per Share | 2.24 | 3.42 | 3.00 | 2.47 | 1.63 | 2.22 | Upgrade
|
| Cash Income Tax Paid | 1,601 | 1,450 | 1,350 | 1,300 | 1,248 | 1,220 | Upgrade
|
| Levered Free Cash Flow | 932.26 | 2,186 | 2,073 | 1,497 | 623.65 | 1,259 | Upgrade
|
| Unlevered Free Cash Flow | 945.6 | 2,206 | 2,089 | 1,524 | 659.16 | 1,289 | Upgrade
|
| Change in Net Working Capital | 609.32 | -659.09 | -572.62 | -156.24 | 428.1 | 178.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.